FORMULIERUNGEN AUS BENDAMUSTIN

European patent · EP3158991 · Deleted

Register entry

Publication number
EP3158991
Application number
EP16020363
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 28, 2011
Published
Apr 26, 2017
Granted
Mar 17, 2021
Deleted
Aug 24, 2022
Reason
Annual fee unpaid
IPC classes
A61K 9/08 (2006.01)
A61K 31/4184 (2006.01)
A61K 47/10 (2017.01)
A61K 47/20 (2006.01)
A61P 35/00 (2006.01)
Priority
US 299100 P 28.01.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 24, 2022

    Deleted, fee unpaid

    Published in Swissreg on 24.08.2022

  2. Jan 26, 2022

    Change

    Published in Swissreg on 26.01.2022

  3. Mar 17, 2021

    Granted

    Published in Swissreg on 17.03.2021

Parties

Holder

Eagle Pharmaceuticals, Inc.

50 Tice Boulevard, Woodcliff Lake, NJ 07677, US

Inventor

Palepu, Nagesh R.

Southampton, Pennsylvania 18966, US

Buxton, Philip Christopher

Great Dunmow, Essex CM6 2PB, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.